High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea · Delayed Price · Currency is KRW 14,400
+100 (0.70%)
At close: Jun 11, 2026
High Tech Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 9,024 | 11,475 | 13,710 | 8,076 | 5,873 | -1,225 |
Depreciation & Amortization | 5,481 | 5,417 | 5,169 | 4,986 | 5,545 | 5,551 |
Loss (Gain) From Sale of Assets | -3 | -3 | - | 9.51 | -68.11 | - |
Loss (Gain) From Sale of Investments | -132.65 | -127.32 | -129.57 | -115.56 | -54.65 | - |
Stock-Based Compensation | 2,783 | 406.36 | 865.15 | - | - | - |
Other Operating Activities | -258.92 | -910.41 | 3,632 | 2,954 | 68.93 | 814.46 |
Change in Accounts Receivable | -734.25 | 8,967 | 5,044 | 3,634 | -20,976 | 10,236 |
Change in Inventory | -12,420 | -9,408 | -9,312 | -10,825 | 3,033 | 1,663 |
Change in Accounts Payable | 1,373 | 1,329 | -3,645 | -4,298 | 3,731 | -6,640 |
Change in Other Net Operating Assets | -1,228 | -117.99 | -641.56 | -1,514 | -854.62 | -3,471 |
Operating Cash Flow | 3,883 | 17,028 | 14,691 | 2,909 | -3,703 | 6,928 |
Operating Cash Flow Growth | -67.30% | 15.91% | 405.08% | - | - | - |
Capital Expenditures | -1,853 | -1,926 | -2,133 | -5,091 | -655.97 | -859.6 |
Sale of Property, Plant & Equipment | 3 | 3 | - | 27.27 | 359 | - |
Investment in Securities | 612.94 | -631.3 | 989.8 | -1,644 | 987.59 | -593.15 |
Other Investing Activities | -22.74 | -22.74 | - | -47.09 | 39.73 | 161.13 |
Investing Cash Flow | -1,260 | -2,577 | -1,143 | -6,755 | 730.36 | -1,292 |
Short-Term Debt Issued | - | - | 5,000 | - | - | 5,000 |
Long-Term Debt Issued | - | - | - | 5,000 | - | - |
Total Debt Issued | - | - | 5,000 | 5,000 | - | 5,000 |
Short-Term Debt Repaid | - | -7,940 | -8,868 | -5,000 | - | - |
Long-Term Debt Repaid | - | -27.57 | -5,028 | -32.89 | -35.68 | -24.83 |
Total Debt Repaid | -7,967 | -7,968 | -13,896 | -5,033 | -35.68 | -24.83 |
Net Debt Issued (Repaid) | -7,967 | -7,968 | -8,896 | -32.89 | -35.68 | 4,975 |
Repurchase of Common Stock | - | - | -5.35 | - | - | - |
Dividends Paid | -1,063 | -1,063 | -708.88 | -496.21 | -354.44 | -354.44 |
Other Financing Activities | - | - | 194.04 | - | - | - |
Financing Cash Flow | -9,030 | -9,031 | -9,416 | -529.11 | -390.12 | 4,621 |
Foreign Exchange Rate Adjustments | -135.27 | -102.63 | 144.15 | -22.05 | -31.48 | -20.22 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | -6,542 | 5,317 | 4,276 | -4,398 | -3,394 | 10,237 |
Free Cash Flow | 2,030 | 15,102 | 12,558 | -2,183 | -4,359 | 6,068 |
Free Cash Flow Growth | -79.48% | 20.25% | - | - | - | - |
Free Cash Flow Margin | 2.94% | 21.52% | 16.20% | -2.84% | -4.23% | 8.28% |
Free Cash Flow Per Share | - | 1411.28 | 1181.10 | -307.89 | -409.94 | 570.68 |
Cash Interest Paid | 150.19 | 581.65 | 806.08 | 564.95 | 422.78 | 169.85 |
Cash Income Tax Paid | 2,870 | 4,347 | 190.11 | 276.96 | 2.78 | 326.48 |
Levered Free Cash Flow | 3,519 | 13,253 | 7,530 | -5,473 | -5,953 | 6,357 |
Unlevered Free Cash Flow | 3,575 | 13,366 | 8,022 | -4,913 | -5,663 | 6,515 |
Change in Working Capital | -13,010 | 770.46 | -8,555 | -13,002 | -15,067 | 1,788 |